Keyphrases
Biomimetic
100%
Tb3+
100%
Apatite Nanoparticles
100%
Diclofenac
100%
Inflammatory Environment
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
50%
Inflammation
33%
Cyclooxygenase-2
33%
Apatite
33%
Prostaglandin E2
33%
Diclofenac Release
33%
Release Rate
16%
Diagnostic Applications
16%
Eu3+
16%
Enzymatic Activity
16%
Citrate
16%
MRNA Expression
16%
Therapeutic Strategies
16%
Nanoparticles
16%
Rheumatoid Arthritis
16%
Central Nervous System
16%
Luminescence Properties
16%
Clinical Conditions
16%
Lanthanide Ions
16%
Primary Osteoblasts
16%
Osteoblast
16%
Therapeutic Use
16%
Osteoarthritis
16%
Analgesic
16%
Osteoporosis
16%
Luminescence
16%
Inflammatory Mediators
16%
Carbonate Apatite
16%
Health Problems
16%
Undoped
16%
Nanocrystals
16%
Adsorption Isotherm
16%
Freundlich Model
16%
Calcium Phosphate
16%
Gastrointestinal Bleeding
16%
Local Inflammation
16%
Osteo
16%
Local Delivery
16%
Adsorbed Amount
16%
Luminescence Emission
16%
Bone Tissue
16%
Bone Apatite
16%
Systemic Side Effects
16%
System Reactions
16%
Musculoskeletal Disorders
16%
Cytocompatible
16%
Population Aging
16%
Inconvenience
16%
Skin Reactions
16%
Inflammation Model
16%
Luminescent Nanoparticles
16%
Luminescence Intensity
16%
Socioeconomic Burden
16%
Osteosarcoma Cell Lines
16%
Release Ability
16%
Localized Delivery
16%
Diclofenac Sodium
16%
Tissue Pathology
16%
Hepatorenal Dysfunction
16%
E2-2
16%
Antipyretic Activity
16%
Gastrointestinal Ulcer
16%
Immunology and Microbiology
Osteoblast
100%
Prostaglandin E2
100%
Biomimetics
100%
Inflammatory Arthritis
50%
Enzyme Activity
50%
Mediator
50%
Central Nervous System
50%
Bone Tissue
50%
Population
50%
Osteoarthritis
50%
Adsorption Isotherm
50%
Osteosarcoma Cell Line
50%
Antipyretic Activity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Diclofenac
100%
Inflammation
50%
Non-Steroidal Anti-Inflammatory Drug
37%
Disease
25%
Side Effect
25%
Cyclooxygenase 2
25%
Prostaglandin E2
25%
Analgesic Agent
12%
Rheumatoid Arthritis
12%
Osteosarcoma
12%
Osteoarthritis
12%
Anti-Inflammatory Drug
12%
Bleeding
12%
Ulcer
12%
Lanthanide
12%
Skin Manifestation
12%
Antipyretic Agent
12%
Calcium Phosphate
12%
Doping
12%
Musculoskeletal Disease
12%
Inflammatory Arthritis
12%
Messenger RNA
12%
Material Science
Nanoparticle
100%
Luminescence
50%
Osteoblast
25%
Cyclooxygenase
25%
Sodium
12%
Adsorption Isotherm
12%
Lanthanide Series
12%
Enzyme Activity
12%